We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Gene Expression Defines Liver Cancer

By Biotechdaily staff writers
Posted on 20 Jun 2002
Investigators using cDNA microarrays to characterize patterns of gene expression in hepatocellular carcinoma (HCC) found consistent differences between the expression patterns in HCC compared with those seen in nontumor liver tissues and were able to distinguish HCC from tumors metastatic to the liver. The study was published in the June 2002 issue of Molecular Biology of the Cell.

The researchers, from Stanford University Medical Center (Palo Alto, CA, USA; www-med.stanford.edu), isolated RNA samples from more than 200 normal and tumor specimens. They labeled the RNA samples with a fluorescent tag and then exposed them to cDNA microarrays comprised of DNA spots from 17,400 human genes. By comparing the pattern of fluorescent spots, the researchers could determine which genes were being expressed at either high or low levels in the tumor samples.

They found consistent differences between the expression patterns in HCC compared with those seen in nontumor liver tissues. The expression patterns in HCC were also readily distinguished from those associated with tumors metastatic to the liver. The global gene expression patterns intrinsic to each tumor were sufficiently distinctive that multiple tumor nodules from the same patient could usually be recognized and distinguished from all the others in the large sample set on the basis of their gene expression patterns alone.

The distinctive gene expression patterns were characteristic of the tumors and not the patient; the expression programs seen in clonally independent tumor nodules in the same patient were no more similar than those in tumors from different patients.

"There is a real opportunity to use this information to develop better and cheaper tests for diagnosis and treatments,” said Dr. Samuel So, associate professor of surgery and director of Stanford's Asian Liver Center. A screening test would be of particular benefit to Asian and Pacific Island populations, which have roughly 10 times the risk of liver cancer than Caucasians because of high rates of chronic hepatitis B infection.



Related Links:
Stanford University Medical Center

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
All-in-One Molecular System
AIO M160

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
20 Jun 2002  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
20 Jun 2002  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
20 Jun 2002  |   BioResearch